PM
Philip Morris International Inc.
NYSE · Consumer Defensive · Tobacco · US
$197.46
−1.22%Year over year
Reported trailing growth
- Revenue
- +8.9%
- EBITDA
- +12.2%
- EBIT
- +13.0%
- EPS
- +31.8%
- Free cash flow
- +41.5%
- Operating cash flow
- +37.1%
Forward estimates
Based on analyst estimates
- Revenue
- +6.6%
- EBITDA
- +24.4%
- EPS
- +29.2%
Three-year CAGR
- Revenue
- +8.6%
- EBITDA
- +11.6%
- EBIT
- +6.7%
- Net income
- +7.8%
- EPS
- +7.7%
- Free cash flow
- +3.1%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026